In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents
- 31 January 1992
- journal article
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 15 (1), 21-34
- https://doi.org/10.1016/0732-8893(92)90053-v
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published CasesClinical Infectious Diseases, 1990
- In vitro activity of saperconazole (R66 905) compared with amphotericin B and itraconazole againstAspergillus speciesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- Itraconazole in opportunistic mycoses: Cryptococcosis and aspergillosisJournal of the American Academy of Dermatology, 1990
- Treatment of invasive aspergillosis with itraconazoleAmerican Journal Of Medicine, 1989
- Early Experience with Itraconazole in Vitro and in Patients: Pharmacokinetic Studies and Clinical ResultsClinical Infectious Diseases, 1987
- Distribution and Activity of Amphotericin B in HumansThe Journal of Infectious Diseases, 1985
- In vitro studies with R 51,211 (itraconazole)Antimicrobial Agents and Chemotherapy, 1984
- Therapy of Murine Aspergillosis with Amphotericin B in Combination with Rifampin or 5-FluorocytosineAntimicrobial Agents and Chemotherapy, 1977
- In Vitro Susceptibility of Isolates of Aspergillus fumigatus and Sporothrix schenckii to Amphotericin BAntimicrobial Agents and Chemotherapy, 1972
- ANTAGONISTS OF NUCLEIC ACID DERIVATIVESJournal of Biological Chemistry, 1954